NVDA

174.99

-1.22%↓

AVGO.US

325.94

+3.95%↑

ORCL

141.41

-2.15%↓

370.82

-2.55%↓

CSCO

80.25

+0.82%↑

NVDA

174.99

-1.22%↓

AVGO.US

325.94

+3.95%↑

ORCL

141.41

-2.15%↓

370.82

-2.55%↓

CSCO

80.25

+0.82%↑

NVDA

174.99

-1.22%↓

AVGO.US

325.94

+3.95%↑

ORCL

141.41

-2.15%↓

370.82

-2.55%↓

CSCO

80.25

+0.82%↑

NVDA

174.99

-1.22%↓

AVGO.US

325.94

+3.95%↑

ORCL

141.41

-2.15%↓

370.82

-2.55%↓

CSCO

80.25

+0.82%↑

NVDA

174.99

-1.22%↓

AVGO.US

325.94

+3.95%↑

ORCL

141.41

-2.15%↓

370.82

-2.55%↓

CSCO

80.25

+0.82%↑

Kodu・Aktsiate loetelu・NCR Voyix Corp

NCR Voyix Corp

Avatud

6.26 -0.63

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

6.15

Max

6.33

Põhinäitajad
By Trading Economics
Sissetulek	95M 78M
Müük	36M 720M
P/E Sektori keskmine	44.571 74.348
Kasumimarginaal	10.833
Töötajad	13,500
EBITDA	23M 95M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+97.89% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	7. mai 2026

Turustatistika
By TradingEconomics
Turukapital	-346M 867M
Eelmine avamishind	6.89
Eelmine sulgemishind	6.26

NCR Voyix Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

6. apr 2026, 23:17 UTC

Tulu

Samsung Forecasts Record First-Quarter Operating Profit

6. apr 2026, 23:00 UTC

Kuumad aktsiad

Stocks to Watch: Health Insurers, Mawson, Owlet

6. apr 2026, 22:13 UTC

Suurimad hinnamuutused turgudel

Health Insurance Shares Gain on 2.48% Medicare Rate Bump

6. apr 2026, 21:46 UTC

Omandamised, ülevõtmised, äriostud

BP 'Optimizes Portfolio' and Sells 13 Thorntons Stores to Giant Oil -- OPIS

6. apr 2026, 17:09 UTC

Suurimad hinnamuutused turgudel

Viridian Shares Fall After Competing Amgen Eye Drug Performs Well

6. apr 2026, 16:56 UTC

Uudisväärsed sündmused

U.S. Released 1.5 Million Bbls of Crude From SPR Last Week, DOE Data Show -- OPIS

6. apr 2026, 14:47 UTC

Suurimad hinnamuutused turgudel

Stereotaxis Shares Rise on FDA Clearance for Synchrony

7. apr 2026, 00:00 UTC

Uudisväärsed sündmused

Ukraine's Lesson for Trump: Military Dominance Opens Waterways -- WSJ

6. apr 2026, 23:58 UTC

Market Talk

Uudisväärsed sündmused

Iran War Will Keep Oil Prices High Through 2Q, Says Westpac -- Market Talk

6. apr 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Iran Cease-Fire -- Market Talk

6. apr 2026, 23:36 UTC

Market Talk

Gold Edges Higher as Investors Focus on U.S.-Iran Conflict -- Market Talk

6. apr 2026, 23:15 UTC

Market Talk

RBA Won't Raise Rates as Australia's Economy Softens Fast -- Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Global Equities Roundup: Market Talk

6. apr 2026, 22:52 UTC

Market Talk

Pro Medicus Unlikely to Complete New Buyback in Full -- Market Talk

6. apr 2026, 22:14 UTC

Market Talk

Correction to Live Cattle Futures Article

6. apr 2026, 20:56 UTC

Market Talk

Mexican Private Consumption Fell in January -- Market Talk

6. apr 2026, 20:50 UTC

Market Talk

Energy & Utilities Roundup: Market Talk

6. apr 2026, 20:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

6. apr 2026, 19:58 UTC

Market Talk

Live Cattle Futures Hit Record High, Hogs Edge Up -- Market Talk

6. apr 2026, 19:11 UTC

Market Talk

U.S. Natural Gas Edges Up in Rangebound Trade -- Market Talk

6. apr 2026, 19:06 UTC

Market Talk

Treasury Yields Decline as a Belligerent Trump Talks to Reporters -- Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Global Energy Roundup: Market Talk

6. apr 2026, 19:03 UTC

Market Talk

Crude Futures Edge Up As Trump's Iran Deadline Nears -- Market Talk

6. apr 2026, 18:36 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 17:59 UTC

Market Talk

Uudisväärsed sündmused

Travel Booking Companies Facing More Demand Uncertainty Than Expected -- Market Talk

6. apr 2026, 17:13 UTC

Omandamised, ülevõtmised, äriostud

Soleno Stock Soars 32% on $2.9 Billion Neurocrine Buyout. Why Its Hunger Drug Is a Different Weight-Loss Play. -- Barrons.com

6. apr 2026, 16:33 UTC

Market Talk

Oil Futures Steady as Market Awaits Trump -- Market Talk

6. apr 2026, 16:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

6. apr 2026, 14:59 UTC

Tulu

Strategy Records a $14.5 Billion Unrealized Loss in First Quarter -- WSJ

Võrdlus sarnastega

Hinnamuutus

NCR Voyix Corp Prognoos

Hinnasiht

By TipRanks

97.89% tõus

12 kuu keskmine prognoos

Keskmine 12.17 USD 97.89%

Kõrge 14 USD

Madal 9 USD

Põhineb 6 Wall Streeti analüütiku instrumendi NCR Voyix Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

6 ratings

Osta

Hoia

Müü

Põhineb 6 analüütiku instrumendi NCR Voyix Corp aktsia reitingul - viimase 3 kuu andmed.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest NCR Voyix Corp

NCR Corporation is a software and services-led enterprise provider in the financial, retail and hospitality, and telecommunications and technology industries. The Company operates through four segments: Banking, Retail, Hospitality, and Telecommunications and Technology (T&T). The Banking segment offers solutions to customers in the financial service industry that power their digital transformation through software, services and hardware to improve efficiency for the financial institution. The Retail segment offers software-defined solutions to customers in the retail industry with digital, to connect retail operations end to end to integrate all aspects of a customer’s operations in indoor and outdoor settings. The Hospitality segment offers technology solutions to customers in the hospitality industry, including table-service, quick-service and fast casual restaurants of all sizes. The T&T segment offers maintenance, managed and professional services using remote management solution.